mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.67 |
0.01 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.01 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |